Form 4: Alkermes Director Sells Shares After Option Exercise

Alkermes plc Director Shane Cooke exercised stock options and subsequently sold 61,200 ordinary shares under a pre-arranged 10b5-1 trading plan.

Summary

• Shane Cooke, a Director of Alkermes plc, engaged in transactions involving the company's ordinary shares on February 2, 2026.
• Cooke exercised employee stock options to acquire 61,200 ordinary shares at an exercise price of $31.64 per share.
• Immediately following the option exercise, Cooke sold a total of 61,200 ordinary shares in two separate transactions.
• The first sale involved 29,087 shares at a weighted average price of $34.3382, with prices ranging from $33.6923 to $34.69.
• The second sale involved 32,113 shares at a weighted average price of $34.7796, with prices ranging from $34.70 to $34.91.
• All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Cooke on February 27, 2025.
• Following these transactions, Cooke's direct beneficial ownership of Alkermes plc ordinary shares stands at 103,744.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction under a pre-arranged plan, which typically has a neutral impact on company sentiment unless the scale of selling is unusually large or frequent, or if it occurs outside of a 10b5-1 plan.

Positives

• The director realized a profit by exercising options at $31.64 and selling shares at weighted average prices of $34.3382 and $34.7796.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating planned financial management rather than an immediate reaction to company news.

Negatives

• Insider selling, even if pre-planned, can sometimes be perceived negatively by some market participants, although the context of option exercise often mitigates this.

Future Outlook

This Form 4 filing, detailing an insider transaction, does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 trading plans, are a common occurrence in publicly traded companies. These plans allow insiders to sell a predetermined number of shares at a predetermined time or price, providing an affirmative defense against insider trading allegations. Such transactions typically reflect an individual's personal financial planning and compensation management rather than a direct signal about the company's immediate operational performance or strategic shifts.

Comparison to Industry Standards

• This transaction is a standard Form 4 filing for an insider exercising options and selling shares, a common practice across industries for executive compensation and personal liquidity.
• The use of a Rule 10b5-1 plan aligns with best practices for corporate governance, providing transparency and mitigating concerns about opportunistic insider trading, similar to practices observed at peer pharmaceutical and biotechnology companies.

Corporate Governance

Related Party Transactions

• The reported transactions involve Shane Cooke, a Director of Alkermes plc, making them related party transactions.

Stakeholder Impact

• Shareholders: May observe the insider selling, but the pre-arranged 10b5-1 plan context suggests it's for personal financial management rather than a negative signal about the company's future prospects.

Key Dates

Recommendation

The transaction represents a director exercising expiring options and selling shares under a pre-arranged 10b5-1 plan, which is a common practice for managing personal finances and compensation. It does not inherently signal a change in the company's fundamental outlook or performance, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Alkermes, ALKS, Insider Trading, Form 4, Stock Options, Share Sale, Shane Cooke, 10b5-1 Plan, Director Transaction